Latest Yale Cancer Center Stories
$20 million project will combine targeted therapies and immunotherapy PHILADELPHIA, April 20, 2015 /PRNewswire-USNewswire/ -- Stand Up To Cancer (SU2C) and the American Cancer Society
The Strategic Alliance Partnership program allows the editorial and marketing teams at OncLive® to bring greater awareness to new approaches to research, clinical care, and education in efforts
New website dedicated to cancer information and treatment launched by Dr.
FT. MYERS, Fla., Dec. 16, 2014 /PRNewswire/ -- NeoGenomics, Inc.
First-of-its-kind agreement between national cancer care leader and NJ’s largest multispecialty physician group Berkeley Heights, NJ (PRWEB) October 23, 2014
Roy S. Herbst M.D., Ph.D. honored at the 15th International Lung Cancer Congress SAN CARLOS, Calif., Aug. 1, 2014 /PRNewswire-USNewswire/ -- The Bonnie J.
The Lung-MAP trial uses a multi-drug, targeted screening approach to match patients with promising new cancer treatments based on their unique tumor profiles BETHESDA, Md., June 16,
A multi-center phase I study using an investigational drug for advanced bladder cancer patients who did not respond to other treatments has shown promising results in patients with certain tumor types.
Will oversee Virginia G.
- Growing in low tufty patches.